Choose Your News
Loading...
Exelixis ([[EXEL]] +0.8%) announces that Health Canada has approved commercialization partner Ipsen Biopharmaceuticals Canada's ([[IPSEY]] +0.3%) marketing... [Read More]
Seeking Alpha Popular Tags
Preview